Incidence of Seizure and Associated Risk Factors in Patients in the Medical Intensive Care Unit (ICU) at Memorial Sloan Kettering Cancer Center (MSK) from 2016–2017
Restricted accessResearch articleFirst published online October, 2022
Incidence of Seizure and Associated Risk Factors in Patients in the Medical Intensive Care Unit (ICU) at Memorial Sloan Kettering Cancer Center (MSK) from 2016–2017
Background: Seizures and status epilepticus are common neurologic complications in the intensive care unit (ICU) but the incidence in a cancer ICU is unknown. It is important to understand seizure risk factors in cancer patients to properly diagnose the seizure type to ensure appropriate therapy. Methods: We identified patients admitted to the medical ICU at Memorial Sloan Kettering Cancer Center (MSK) from January 2016 to December 2017 who had continuous or routine electroencephalography (EEG) and identified clinical and electrographic seizures by chart review. Results: Of the 1059 patients admitted to the ICU between 2016 and 2017, 50 patients had clinical and/or electrographic seizures (incidence of 4.7%, 95% CI: 3.4-6.0). The incidences of clinical and electrographic seizure were 4.1% and 1.1%, respectively. In a multivariable stepwise regression model, history of seizure (OR: 2.9, 95% CI: 1.1-7.8, P: .03), brain metastasis (OR: 2.5, 95% CI: 1.1-5.8, P: .03), vasopressor requirement (OR: 2.2, 95% CI: 1.0-4.9, P: .05), and age < 65 (2.4, 95% CI: 1.2-5.0, P: .02) were associated with increased risk of seizure (either clinical or electrographic). Obtaining continuous EEG instead of routine EEG increased the yield of seizure detection significantly (OR: 3.9, 95% CI: 1.3-11.1, P: .01). No chemotherapy in the past 30 days, no antibiotic use, vasopressor requirement, and having a brain tumor increased risk of electrographic seizure. Length of continuous EEG > 24 h significantly increased the chances of both clinical and electrographic seizure detection, (OR: 2.6 [95% CI: 1.2-5.7] and 15.0 [95% CI: 2.7-82.5], respectively). Conclusions: We identified known and cancer-related risk factors which can aid clinicians in diagnosing seizures in cancer ICUs. Long-term video EEG monitoring should be considered, particularly given the treatable and reversible nature of seizures.
OddoMCarreraEClaassenJMayerSAHirschLJ. Continuous electroencephalography in the medical intensive care unit. Crit Care Med. 2009;37(6):2051-2056.
2.
VespaPMO’PhelanKShahM, et al.Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003;60(9):1441-1446.
3.
KamelHBetjemannJPNaviBB, et al.Diagnostic yield of electroencephalography in the medical and surgical intensive care unit. Neurocrit Care. 2013;19(3):336-341.
4.
ClaassenJMayerSAKowalskiRGEmersonRGHirschLJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62(10):1743-1748.
5.
HermanSTAbendNSBleckTP, et al.Consensus statement on continuous EEG in critically ill adults and children, part I: indications. J Clin Neurophysiol. 2015;32(2):87-95.
6.
ClaassenJTacconeFSHornP, et al.Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM. Intensive Care Med. 2013;39(8):1337-1351.
7.
LowensteinDHAminoffMJ. Clinical and EEG features of status epilepticus in comatose patients. Neurology. 1992;42(1):100-104.
8.
TowneARWaterhouseEJBoggsJG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology. 2000;54(2):340-345.
9.
ShuklaCBanksG. To determine the incidence of seizures detected on continuous EEG (cEEG) monitoring and time of onset to the first seizure on prolonged cEEG in adult patients in neuro intensive care unit (NICU). (P2.089). Neurology. 2015;84(14Suppl):P2.089.
10.
DennisLJClaassenJHirschLJEmersonRGConnollyESMayerSA. Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurgery. 2002;51(5):1136-1143. discussion 44.
11.
KapurJElmJChamberlainJM, et al.Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381(22):2103-2113.
12.
DrislaneFWLopezMRBlumASSchomerDL. Detection and treatment of refractory status epilepticus in the intensive care unit. J Clin Neurophysiol. 2008;25(4):181-186.
13.
AbendNSArndtDHCarpenterJL, et al.Electrographic seizures in pediatric ICU patients: cohort study of risk factors and mortality. Neurology. 2013;81(4):383-391.
14.
WolpertFLareidaATerzievR, et al.Risk factors for the development of epilepsy in patients with brain metastasis. Neuro Oncol. 2020;22(5):718-728.
15.
RossettiAOStuppR. Epilepsy in brain tumor patients. Curr Opin Neurol. 2010;23(6):603-609.
16.
KerkhofMVechtCJ. Seizure characteristics and prognostic factors of gliomas. Epilepsia. 2013;54(Suppl 9):12-17.
17.
SansevereAJDuncanEDLibensonMHLoddenkemperTPearlPLTaskerRC. Continuous EEG in pediatric critical care: yield and efficiency of seizure detection. J Clin Neurophysiol. 2017;34(5):421-426.
18.
PandianJDCascinoGDSoELMannoEFulghamJR. Digital video-electroencephalographic monitoring in the neurological-neurosurgical intensive care unit: clinical features and outcome. Arch Neurol. 2004;61(7):1090-1094.
